Advertisement

Basic Models of Tumor-Immune System Interactions Identification, Analysis and Predictions

  • V. A. Kuznetsov
Part of the Modeling and Simulation in Science, Engineering, & Technology book series (MSSET)

Abstract

The purpose of this chapter is to consider the basic mathematical models of the interaction of cytotoxic cells and effector molecules of the immune system with tumor cells at the effector stage of an anti-tumor immune response. The logic and design lines of some models relevant for tumor immunology will be reviewed and discussed. Special attention is given to validation problems. Mathematical models of the kinetics of interaction of natural killer cells, lymphokine-activated killer cells, cytotoxic T lymphocytes and tumor will be discussed in detail. Some models of the regulation of cellular cytolytic reactions by nonkiller immune cells and by regulatory immune molecules (antibodies, lectins) will be presented. Predictions of kinetic models by a new theoretical concept describing the recognition of target cells without any specific NK-receptor by NK-like cells will been described. Mathematical models of the propagation and interaction of tumorspecific immune molecules (monoclonal antibodies, cytokines) with tumor cells in multicellular tumors are used for analysis of restriction mechanisms for delivering the toxic factor into a solid tumor.

Keywords

Natural Killer Natural Killer Cell Human Natural Killer Cell Multicellular Tumor Spheroid Cytotoxic Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [ABa]
    Abrahms S.I. and Brahmi Z., The functional loss of human natural killer cell activity induced by K-562 is reversible via interleukin-2-dependent mechanisms, Cellular Immunology, 101 (1986), 558–570.CrossRefGoogle Scholar
  2. [ABb]
    Abrahms S.I. and Brahmi Z., Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assay, Ann. Inst. Pasteur Immunology, 139 (1988), 361–381.CrossRefGoogle Scholar
  3. [ADa]
    Adam J.A., General aspects of modeling tumor growth and immune response, in A Survey of Models for Tumor-Immune System Dynamics, Adam J.A. and Bellomo N. eds., Birkhäuser (1996).Google Scholar
  4. [BAa]
    Bardsley W.G., The quantitative analysis of ligand binding and initial rate data for allosteric and other complex enzyme mechanisms, Biochem. J., 153 (1975), 101–117.Google Scholar
  5. [BAb]
    Bardsley W.G., Simple enzyme kinetic mechanisms that can give all possible velocity profiles with chemically reasonable rate constant values, J. Theor. Biol, 104 (1983), 485–491.CrossRefGoogle Scholar
  6. [BDa]
    Bradley T.P. and Bonavida B., Mechanism of cell-mediated cytotoxicity at the single cell level, J. Immunology, 129 (1982), 2260–2265.Google Scholar
  7. [BKa]
    Berke G., The cytolytic T lymphocyte and its mode of action, Immunology Letters, 20 (1989), 169–178.CrossRefGoogle Scholar
  8. [BKb]
    Berke G., The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects, Ann. Rev. Immunology, 12 (1994), 735–773.CrossRefGoogle Scholar
  9. [BKc]
    Berke G., Unlocking the secrets of CTL and NK cells, Immunology Today, 16 (1995), 343–347.CrossRefGoogle Scholar
  10. [BLa]
    Bloom E.I. and Korn E.L., Quantification of natural cytotoxicity by human lymphocyte subpopulations isolated by density: Heterogeneity the effector cells, J. Immun. Meth., 58 (1983), 303–335.CrossRefGoogle Scholar
  11. [BLb]
    Bloom E.I. and Babbitt J.T., Monocyte-mediated augmentation of human natural cell-mediated cytotoxicity, Cellular Immunology, 91 (1995), 21–32.CrossRefGoogle Scholar
  12. [BOa]
    Bonavida B., Bradley T.P., and Grimm E.A., The single-cell assay in cell-mediated cytotoxicity, Immunology Today, 4 (1983), 196–200.CrossRefGoogle Scholar
  13. [BOb]
    Bonavida B., Lebow L.T., and Bradley T.P., Mechanism of cell-mediated cytotoxicity at all single cell level. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates, J. Immunology, 132 (1984), 594–598.Google Scholar
  14. [BRa]
    Berezin I.V. and Varfolomeev S.R., Biokinetics, Nauka (1979) (in Russian).Google Scholar
  15. [BUa]
    Burnet F.M., Cellular Immunology, Melbourne University Press (1969).Google Scholar
  16. [BXa]
    Baxter L.T. and Jain R.K., Transport of fluid and macromolecules in tumors. Role of interstitial and convection, Microvasc. Res., 37 (1989), 77–104.CrossRefGoogle Scholar
  17. [BZa]
    Bezouska K., Yuen C.-T., O’Brien J., Childs R.A., Chai W., Lawson A.M., Drbal K., Riserova A., Pospisil M., and Feizi T., Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity, Nature, 372 (1994), 150–157.CrossRefGoogle Scholar
  18. [CAa]
    Callewaert D.M., Johnson D.F., and Kearney J., Spontaneous cytotoxicity of cultured human cell lines mediated by normal peripheral blood lymphocytes. I. Kinetic parameters, J. Immunology, 121 (1978), 710–717.Google Scholar
  19. [CAb]
    Callewaert D.M., Meyers P., Hiernaux J., and Radcliff G., Kinetics of cellular cytotoxicity mediated by cloned cytotoxic T lymphocytes, Immunobiology, 178 (1988), 203–214.CrossRefGoogle Scholar
  20. [CAc]
    Callewaert D.M., Radcliff G., Waite R., LeFevre J., and Poulik M.D., Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry, Cytometry, 12 (1991), 666–676.CrossRefGoogle Scholar
  21. [CLa]
    Chaplain M., From mutation to metastasis: The mathematical modelling of the stages of tumour development, in A Survey of Models for Tumor-Immune System Dynamics, Adam J.A. and Bellomo N. eds., Birkhäuser (1996).Google Scholar
  22. [COa]
    Colmeraver M.E., Loziol I.A., and Pilch V.H., Enhancement of metastasis development by BCG immunotherapy, J. Surg. Oncology, 15 (1980), 235–241.CrossRefGoogle Scholar
  23. [CPa]
    Cooper E.L., Phylogenesis of cytotoxicity, Endeavors, 4 (1980), 160–165.CrossRefGoogle Scholar
  24. [CRa]
    Cornish-Bowden A., Principles of Enzyme Kinetics, Butter-worths (1976).Google Scholar
  25. [CUa]
    Chu G., The kinetics of target cell lysis by cytotoxic T lymphocytes: A description by Poisson statistics, J. Immunology, 120 (1978), 1261–1267.Google Scholar
  26. [DVa]
    De Vries J.E., Mendelson J., and Bont A., The role of target cell monocytes and Fc receptor bearing lymphocytes in human spontaneous cell-mediated, J. Immunology, 125 (1980), 396–405.Google Scholar
  27. [FEa]
    Ferrarini M., Heltai S., Toninelly E., Sabbadini M.G., Pellicciari C., and Manfredi A.M., Daudi lymphoma killing triggers the programmed death of cytotoxic Vγ9/Vδ2 T lymphocytes, J. Immunology, 154 (1995), 3704–3712.Google Scholar
  28. [FIa]
    Figdor C.B., van Kooyk Y., and Keizer G.D., On the mode of action of LFA, Immunology Today, 11 (1990), 277-280.Google Scholar
  29. [FOa]
    Foa C., Bongrand P., Galindo J.R., and Golstein P.J., Unexpected cell surface labeling in conjugates between cytotoxic T lymphocytes and target cells, Histochem. and Cytochem., 33 (1985), 647–657.CrossRefGoogle Scholar
  30. [FRa]
    Forni G., Parmiani G., Guarini A., and Foa R., Gene transfer in tumor therapy, Annals of Oncology, 5 (1994), 789–794.Google Scholar
  31. [GAa]
    Garay R.P. and Lefever R., A kinetic approach to the immunology cancer stationary state properties of effector-target reaction, J. Theor. Biol., 73 (1978), 417–438.MathSciNetCrossRefGoogle Scholar
  32. [GEa]
    Gergely J. and Sarmay G., IgG-Fc-receptors: Ligand binding and lysis induction, Immunology Letters, 20 (1989), 1–4.CrossRefGoogle Scholar
  33. [GOa]
    Goud B. and Antoine J.C., Emergence of a surface immunoglobulin recycling process during B lymphocyte differentiation J. Cell. Biol., 48 (1984), 1238–1246.CrossRefGoogle Scholar
  34. [GRa]
    Griffiths G.M., The cell biology of CTL killing, Current Opinion in Immunology, 7 (1995), 343–348.CrossRefGoogle Scholar
  35. [GUa]
    Gumpertz J.E. and Parhan P., The enigma of natural killer cell, Nature, 378 (1995), 245–248.CrossRefGoogle Scholar
  36. [HEa]
    Herberman R.B., Vujanovic N., Rabinowich H., and Whitside T.L., Natural killer cells and interleukin-2-activated killer cells, in Lym-phohaemotopoietic Growth Factors in Cancer Therapy, II, Mertelsmann R. ed., Springer (1993), 11–27.Google Scholar
  37. [HGa]
    Hoang T., Tsodikov A., Yakovlev A., and Asselain B., Modeling breast cancer recurrence, in Mathematical Population Dynamics: Analysis of Heterogeneity, Vol. II, Arino O., Axelrod D., and Kimmel M. eds., Wuerz Publishing Ltd. (1995), 283–296.Google Scholar
  38. [HIa]
    Hiserodt J.C., Britvan L.J., and Targan S.R., Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: Resolution into binding, programming and killer cell-independent steps, J. Immunology, 131 (1983), 2710–2713.Google Scholar
  39. [HKa]
    Herrick M.V. and Pollack S.B., Kinetic analysis of antibody dependent cellular cytotoxicity: Evidence for noncompetitive inhibition by autologous lymphoid cells, J. Immunology, 121 (1978), 1348–1352.Google Scholar
  40. [HRa]
    Herlyn M. and Koprowski H., Melanoma antigens: Immunological and biological characterization and clinical significance, Ann. Rev. Immunology, 6 (1988), 299–308.Google Scholar
  41. [IHa]
    Iho S. and Shau H., Role of enhanced cellular adhesion in IL-6-augmented lymphokine-activated killer-cell function, Scand. J. Immunol, 39 (1993), 233–240.CrossRefGoogle Scholar
  42. [IVa]
    Ivshina A.V., Kuznetsov V.A., and Kadagidze Z.G., Interaction of the human natural killer cells with target cells. The quantity estimations, in Dynamics of Biological Populations, Goryachenko D.D. ed., Gor’ki State Univ. Press (1985), 72–83 (in Russian).Google Scholar
  43. [JEa]
    Jenski L.J., Kinetic assay of cytotoxic T lymphocyte clones II: Comparison of primary and secondary responses and lectin-dependent cytotoxicity. J. Immunol. Meth., 117 (1989), 191–198.CrossRefGoogle Scholar
  44. [JNa]
    Jain R.K., Barriers to drug delivery in solid tumors, Sci. Amer., 271 (1994), 58–65.CrossRefGoogle Scholar
  45. [JUa]
    Jung G. and Eberhard H.J.M., An in vitro model for tumour immunotherapy with antibody heteroconjugates, Immunology Today, 9 (1988), 257–260.CrossRefGoogle Scholar
  46. [JWa]
    Juweid M., Neumann R., and Paik Ch., Micropharmacology of monoclonal antibodies in solid tumors: Direct experimental evidence for a binding site barrier, Cancer Res., 52 (1992), 5144–5153.Google Scholar
  47. [KAa]
    Karre K., Hanson M., and Kiesling R., Multiple interactions at the natural killer workshop, Immunology Today, 12 (1991), 343–345.CrossRefGoogle Scholar
  48. [KIa]
    Kimber I. and Moore M., Mechanism and regulation of natural cytotoxicity, Exp. Cell. Biol., 53 (1985), 69–84.Google Scholar
  49. [KKa]
    Kwok C.S., Cole S.E., and Liao S.K., Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids, Cancer Res., 48 (1988), 1856–1863.Google Scholar
  50. [KKb]
    Kwok C.S., Crivici A., MacGregor W.D., and Unger M.W., Optimization of radioimmunotherapy using human malignant melanoma multicellspheroids as a model, Cancer Res., 49 (1989), 3276–3281.Google Scholar
  51. [KNa]
    Konev C.B., Structural Liability of Biological Membranes and Regulatory Processes, Nauka & Technika (1987) (in Russian).Google Scholar
  52. [KOa]
    Kometiany Z.P. and Vekua M.G., Kinetics of Membrane Enzymes, Vysshaya Shkola (1988) (in Russian).Google Scholar
  53. [KUa]
    Kunisch K. and Scheich H., Parameter estimation in a spatial reaction diffusion system modelling man-environment diseases, J. Math. Biology, 27 (1989), 633–665.MATHCrossRefGoogle Scholar
  54. [KWa]
    Kawade Y., Neutralization of activity of effector protein by monoclonal antibody: Formulation of antibody dose-dependence, of neutralization for an equilibrium system of antibody, effector and its cellular receptor, Immunology, 56 (1985), 497–504.Google Scholar
  55. [KZa]
    Kuznetsov V.A., The dynamics of cellular immunological antitumor reactions. I. Synthesis of a multi-level model, in Mathematical Methods of Systems Theory, Fedorov V.D. ed., Kyrghiz State Univ. Press, 1 (1979), 57–71 (in Russian).Google Scholar
  56. [KZb]
    Kuznetsov V.A. and Volkenshtein M.V., Dynamics of immunological cellular antitumor reactions. II. Qualitative analysis of the model, in Mathematical Methods of Systems Theory, Fedorov V.D. ed., Kyrghiz State Univ. Press, 1 (1979), 72–100 (in Russian).Google Scholar
  57. [KZc]
    Kuznetsov V.A., Asymptotics of solutions of the singular perturbation problems in study of the enzyme-like kinetics equation system, in Studying of Integral Differential Equations, Imanaliev M. ed., Ilym, 15 (1982), 262–270 (in Russian).Google Scholar
  58. [KZd]
    Kuznetsov V.A., Analysis of population dynamics of cells exhibiting natural resistance to tumors, Soviet Immunology, 3 (1984), 58–68.Google Scholar
  59. [KZe]
    Kuznetsov V.A., Ivshina A.V., and Kadaghidze Z.G., Computerized determination of the number of active natural killer cells, their avidity and rate of recycling during lytic cycle, Soviet Immunology, 5 (1988), 33–38.Google Scholar
  60. [KZf]
    Kuznetsov V.A., Dynamics of Immune Processes During Tumor Growth, Nauka (1992) (in Russian).Google Scholar
  61. [KZg]
    Kuznetsov V.A., The NK cell recognition of target-cells without specific NK-receptor: A biophysical model, Immunologiya, 3 (1992), 8–13 (in Russian).Google Scholar
  62. [KZh]
    Kuznetsov V.A. and Stepanova L.A., Space-time waves and dissipa-tive structures in a model of growth of tumors infiltrated by immune lymphocytes, in Lecture Notes of the ICB Seminars Biosystems, Marchuk G. and Werynski A. eds., Intern. Center of Biocy-bernetics (1992), 68–111.Google Scholar
  63. [KZi]
    Kuznetsov V.A., Zhivoglyadov V.P., and Stepanova L.A., Kinetic approach and estimation of parameters of cellular interaction between immune system and a tumor, Archivium Immunologiae et Therapie Experimentalis, 41 (1993), 21–32.Google Scholar
  64. [KZj]
    Kuznetsov V.A., Makalkin I., Taylor M.A., and Perelson A.S., Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcations analysis, Bull. Mathem. Biology, 56 (1994), 295–321.MATHGoogle Scholar
  65. [KZk]
    Kuznetsov V.A. and Borisova L.P., Kinetics model of the interleukin-4 (IL-4) binding to high affinity IL-4 receptor and their internalization, in Differential Equations and Applications to Biology and to Industry, Martelli M., Cooke K., Cumberbatch E., Tang B., and Thieme H. eds., World Scientific (1995), 271–280.Google Scholar
  66. [KZl]
    Kuznetsov V.A., Ivshina A.V., Sen’ko O.V., and Kuznetsova A.Z., Syndrome approach for computer recognition of fuzzy systems and its application to immunological diagnostics and prognosis of human cancer, Math. Comput. Modeling, 23 (1996), 92–112.CrossRefGoogle Scholar
  67. [KZn]
    Kuznetsov V.A., “Harpoon” model for cell-cell adhesion and recognition of target cells by the natural killer cells, J. Theor. Biol. (1996) to appear.Google Scholar
  68. [LEb]
    Lefever R., Hiernaux J., Urbain J., and Meyers P., On the kinetics and optimal specificity of cytotoxic reactions mediated by T lymphocyte clones, Bull. Math. Biol., 54 (1992), 839–873.MATHGoogle Scholar
  69. [LKa]
    Look A.T., Schriber T.J., Nawrocki J.F., and Murphy W.H., Computer simulation of the cellular immune response to malignant lymphoid cells logic of approach model design and laboratory verification, Immunology, 43 (1981), 677–690.Google Scholar
  70. [LMa]
    Lumb J.R., The value of theoretical models in immunological research, Immunology Today, 4 (1983), 209–210.CrossRefGoogle Scholar
  71. [LOa]
    Lomakin M.S., Immunobiological Surveillance, Medicine (1990) (in Russian).Google Scholar
  72. [LUa]
    Liu M.A., Kranz D.M., Kurnick J.T., Boyle L.A., Levy R., and Eisen H.N., Maintenance and cure of the L5178 murine tumour dormant state by lnterleukin-2: In vivo and in vitro effects, Proc. Natl. Acad. Sci. USA, 82 (1985), 3648–8652.Google Scholar
  73. [LWa]
    Leeuwenberg J.F., Spitz H., Tax W.J., and Capel P.J.A., Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies, J. Immunology, 134 (1985), 3770–3775.Google Scholar
  74. [MAa]
    Macken C.A. and Perelson A.S., Aggregation of cell surface receptors by multivalent ligands, J. Immunology, 132 (1984), 1614–1624.Google Scholar
  75. [MCa]
    Michelson S. and Leith J.T., Tumor heterogeneity and growth control, in A Survey of Models for Tumor-Immune System Dynamics, Adam J.A. and Bellomo N. eds., Birkhäuser (1996).Google Scholar
  76. [MEa]
    Meuer S.C., Hussey R.E., Hodgon J.C., Hercend T., Schlossman S.E., and Reinherz E.L., Lymphocyte mediated lysis, Science, 218 (1982), 471–473.CrossRefGoogle Scholar
  77. [MFa]
    McFadden R. and Kwok C.S., Mathematical model of simultaneous diffusion and binding of antitumor antibodies in multicellular human tumor spheroids, Cancer Res., 48 (1988), 4032–4037.Google Scholar
  78. [MHa]
    Mahle N.H., Radclif G., Sevella C.L., Kornbluth J., and Callewaert D.M., Kinetics of cellular cytotoxicity mediated by a cloned human natural killer cell line, Immunobiol., 179 (1989), 230–243.CrossRefGoogle Scholar
  79. [MIa]
    Miller R.G. and Dunkley M., Quantitative analysis of the Cr release cytotoxicity assay for cytotoxic lymphocytes, Cellular Immunology, 14 (1974), 284–292.CrossRefGoogle Scholar
  80. [MKa]
    McKinnon D. and Hodgkin P.D., A model of a T cell-target interaction leading to lymphokine release, Immunol. Cell. Biol., 65 (1987), 443–451.CrossRefGoogle Scholar
  81. [MLa]
    Merrill S.J., Foundation of the use of enzyme kinetic analogy in cell-mediated cytotoxicity, Math. Biosciences, 62 (1982), 219–236.MathSciNetMATHCrossRefGoogle Scholar
  82. [MLb]
    Merrill S.J. and Sathananthan S., Approximation Michaelis-Menten kinetics displayed in a stochastic model of cell-mediated cytotoxicity, Math. Biosci., 80 (1986), 223–238.MathSciNetMATHCrossRefGoogle Scholar
  83. [MMa]
    Mellman J. and Plutner P., Internalization and rapid recycling by macrophage Fc-receptors with monovalent antireceptor antibodies a possible role of relysomal compartment, J. Cell. Biol., 98 (1984), 1163–1169.CrossRefGoogle Scholar
  84. [MOa]
    Moretta A., Vitale M., Sivori S., Bottino C., Morelli L., Angagliaro R., Bararesi M., Pele O., Ciccone E., Lopez-Bolet M., and Moretta L., Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp 43 (CD 94) molecule functions as receptors for HLA-B alleles, J. Exp. Med., 180 (1994), 454–555.CrossRefGoogle Scholar
  85. [MTa]
    Martz E., Mechanism of specific tumor cell lysis by alloimmune T lymphocytes: Resolution and characterization of descreate stages in cellular interaction, Contemporary Topics in Immunology, 7 (1977), 301–361.CrossRefGoogle Scholar
  86. [MUa]
    Murray J.D., Lectures on Nonlinear Equation Models in Biology, Clarendon Press (1977).Google Scholar
  87. [NUa]
    Nugent L.J. and Jain R.K., Extravascular diffusion in normal and neoplastic tissues, Cancer Res., 44 (1984), 238–244.Google Scholar
  88. [ONa]
    Ong G.L. and Mattes M.J., Penetration and binding of antibodies in experimental human solid tumors grown in mice, Cancer Res., 49 (1989), 4264–4273.Google Scholar
  89. [ORa]
    Ortaldo J.R., Glenn G.M., Yong H.A., and Frey J.L., Natural killer (NK) cell dysfunction and putative NK cell receptor expression abnormality in members of a family with chromosome 3p-linked von Hippel-Lindau disease, J. Natl. Cancer Inst., 84 (1992), 1897–1902.CrossRefGoogle Scholar
  90. [PAa]
    Pankov P.S., Kuznetsov V.A., and Kenenbaeva G.M., Algorithm of the global search and the program package for approximation of kinetic experimental data at known measure errors, Preprint Inst, of Chem. Phys. of USSR Acad, of Sciences, Moscow (1990), 42 (in Russian).Google Scholar
  91. [PEa]
    Perelson A.S. and Bell G.I., Delivery of lethal hits by cytotoxic T lymphocytes in multicellular conjugates occurs sequentially but at random times, J. Immunology, 129 (1982), 2796–2801.Google Scholar
  92. [PEb]
    Perelson A.S., Macken C.A., Grimm E.A., Roos L.S., and Bonavida B., Mechanism of cell-mediated cytotoxicity at the single cell level. V. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte, J. Immunology, 132 (1984), 2190–2198.Google Scholar
  93. [PLa]
    Pollack S.B. and Emmons S.L., Kinetic analysis of human spontaneous cell-mediated cytotoxicity, J. Immunology, 123 (1979), 160–165.Google Scholar
  94. [PRa]
    Prehn R., Stimulatory effects of immune reactions upon the growth of untransplantated tumors, Cancer Res., 54 (1994), 908–914.Google Scholar
  95. [PSa]
    Pross H.F., Callewaert D., and Rubin P., Assays for NK cell cytotoxicity: Their values and pitfalls, in Immunobiology of Natural Killer Cells, Lotzova E. ed., CRC Press (1986), 1–20.Google Scholar
  96. [PVa]
    Provinciali M., Fabris N., and Pieri C., Improvement of natural killer cell activity by in vitro active lipids (AL 721) administration in old mice, Mechanisms of Aging and Development, 52 (1990), 245–254.CrossRefGoogle Scholar
  97. [PZa]
    Perez P., Bluestone J.A., Stephany D.A., and Segal D.M., Quantitative measurements of the specificity and kinetics of conjugate formation between cloned cytotoxic T lymphocytes and splenic target cells by dual parameter flow cytometry, J. Immunology, 134 (1985), 478–485.Google Scholar
  98. [REa]
    Reiter Z., Reiter Y., Fishelson Z., Shinitzky M., Kessier A., Loyter A., Nussbaum O., and Rubinstein M., Resistance to NK cell mediated cytotoxicity (in K-562 Cells) does not correlate with Class I MHC antigen levels, Immunology, 183 (1991), 23–39.Google Scholar
  99. [ROa]
    Robertson M.J., Caliguiri M.A., Manley T.J., Levine H., and Ritz J., Biphasic responses, signals and cellular behaviour, J. Immunology, 145 (1990), 3194–3201.Google Scholar
  100. [RZa]
    Roozemond R.C. and Bonavida B., Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells, J. Immunology, 134 (1985), 2209–2214.Google Scholar
  101. [RZb]
    Roozemond R.C. and Bonavida B., Effect of altered membrane structure on NK-mediated cytotoxicity: Conversion of NK-resistant tumour cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes, J. Immunology, 136 (1986), 3921–3928.Google Scholar
  102. [RZc]
    Roozemond R.C., van der Geer P., and Bonavida B., NK-resistant tumor cells become susceptible to NK lysis upon fusion with reconstituted liposomes containing NK-sensitive membrane structures, in Membrane-Mediated Cytotoxicity, Bonavida B. and Coller R.J. eds., Liss (1987), 173–187.Google Scholar
  103. [SAa]
    Sakharov D.V., Matveev M.Yu., and Domogatsky S., Binding of affinity ligand with a three-dimensional target: The role of diffusion limitations, Biophysika, 36 (1991), 49–54 (in Russian).Google Scholar
  104. [SEa]
    Segel L.A., On the validity of the steady state assumption of enzyme kinetics, Bull, of Math. Biol., 50 (1988), 579–593.MathSciNetMATHGoogle Scholar
  105. [SHa]
    Sharon N., Surface carbohydrates and surface lectins are recognition determinants in phagocytosis, Immunology Today, 5 (1984), 143–147.CrossRefGoogle Scholar
  106. [SNa]
    Seung L.P., Seung S.K., and Schereiber H., Antigenic cancer cells that escape immune destruction are stimulated by the host cells, Cancer Res., 55 (1995), 5094–5100.Google Scholar
  107. [SOa]
    Solono-Munoz G., McGinley P.B., Woolfson R., and Bardsley W.G., Deviations from Michaelis-Menten kinetics, Biochem. J., 193 (1981), 339–352.Google Scholar
  108. [SUa]
    Shau H. and Golub H., Modulation of natural killer-mediated lysis by red blood cells, Cellular Immunology, 116 (1988), 60–72.CrossRefGoogle Scholar
  109. [TEa]
    Thiele D.L. and Lipsky E., The role of cell surface recognition structures in the initiation of MHC-unrestricted “promiscuous” killing by T cells, Immunology Today, 10 (1989), 375–381.CrossRefGoogle Scholar
  110. [THa]
    Thoma J.A., Thoma G.J., and Clark W., The efficiency linearity of the radiochromium release assay for cell-mediated cytotoxicity, Cellular Immunology, 40 (1978), 404–418.CrossRefGoogle Scholar
  111. [TIa]
    Timonen T., Patarroyo M., and Gahmberg C.G., CDIIa-c/CD18 and GP84(LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing, J. Immunology, 141 (1988), 1041–1046.Google Scholar
  112. [TRa]
    Thorn R.M. and Henny C.S., Enumeration of specific cytotoxic T cells, Nature, 262 (1976), 75–77.CrossRefGoogle Scholar
  113. [TRb]
    Thorn R.M. and Henny C.S., Kinetic analysis of target cell distinction by effector T cells. I. Delineation of parameters related to the frequency, J. Immunology, 117 (1976), 2213–2219.Google Scholar
  114. [TRc]
    Thorn R.M. and Henny C.S., Kinetic analysis of target cells distinction by effector T cells. II. Changes in killer cell avidity as function of time and dose, J. Immunology, 119 (1977), 1973–1978.Google Scholar
  115. [TUa]
    Tutt A., Greenman J., Stevenson G.T., and Glennie M.J., Bispecific F(abγ)3 antibody derivatives for redirecting unprimed cytotoxic T cells, Eur. J. Immunology, 21 (1991), 1351–1358.CrossRefGoogle Scholar
  116. [ULa]
    Ullberg M. and Jondal M., Recycling and target binding capacity of human natural killer cells, J. Exp. Med., 153 (1981), 615–628.CrossRefGoogle Scholar
  117. [VAa]
    Vasiljeva L.B. and Butuzov V.F., Asymptotic Analysis, Nauka (1973) (in Russian).Google Scholar
  118. [VIa]
    Vitolo D., Vujanovic N.L., Rabinowich H., Schlesinger M., Herber-man R.B., and Whiteside T.L., Rapid Il-2-induced adherence of human natural killer cells: Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells, J. Immunology, 151 (1993), 1926–1937.Google Scholar
  119. [VOa]
    Van Oers M.H.J., De Goede R.E.Y., and Zeijlemaker W.R, Antibody dependent cytotoxicity: An analysis of effector cell-target cell interactions, J. Immunology, 121 (1978), 499–504.Google Scholar
  120. [WEa]
    Weinstein J.N. and Van Osdol W., Early intervention in cancer using monoclonal antibodies and other biological ligands: Microphar-macology and the “binding site barrier”, Cancer Res., 52 (1992), 2747–2751.Google Scholar
  121. [YOa]
    Yokoyama W.M. and Seaman W.E., The Ly-49 and NKR-1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex, Annual Rev. Immunology, 11 (1993), 613–635.CrossRefGoogle Scholar
  122. [ZEa]
    Zeijlemaker W.P., van Oers R.H., deCoede R.E., and Schellekens P.T., Cytotoxic activity of human lymphocytes: Quantitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics, J. Immunology, 119 (1977), 1507–1514.Google Scholar
  123. [ZUa]
    Zugary D., Bernardi J., and Jeannesson P., Studies on the mechanism of T-cell lethal hits and target cell lysis in multicellular conjugates, J. Immunology, 123 (1979), 1604–1609.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • V. A. Kuznetsov
    • 1
  1. 1.Division of Cellular and Gene Therapies Laboratory of Molecular Tumor BiologyCenter for Biologics Research and Evaluation, FDABethesdaUSA

Personalised recommendations